Loading chat...
NY A02012
Bill
Status
1/14/2025
Primary Sponsor
Brian Maher
Click for details
AI Summary
-
Opioid settlement fund advisory board would direct the Health Commissioner to study 250 random anonymous urine samples from overdose patients across all New York counties
-
Samples must be collected only from patients diagnosed with moderate to severe opioid overdose symptoms, particularly those not responding to Narcan or experiencing unusual symptoms, with full informed consent
-
Testing would use advanced laboratory techniques (LC-MS-MS and GC-MS) to identify new opioid analogs, xylazine, unidentified compounds, and illicit drug combinations
-
Samples cannot be used for law enforcement, child welfare investigations, probation/parole purposes, or included in patient medical records
-
Commissioner of Health must publish a report within one year with statewide treatment protocols and emergency room procedures, submitted to the Governor, legislature, and made available to hospitals and addiction treatment facilities
Legislative Description
Directs the commissioner of health to conduct a study to identify, analyze, report, and medically combat new or previously unseen opiate/opioid compounds found in overdose patients in New York state for the purpose of establishing more efficient overdose medical treatment protocols.
Last Action
referred to health
1/7/2026